CYCN - Cyclerion Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.39 -0.07 (-2.9%)	---	---	---	0.0 (0.0%)	0.02 (0.85%)	-0.09 (-3.7%)	-0.09 (-3.7%)

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.11
Diluted EPS:: -0.11
Basic P/E:: -21.0982
Diluted P/E:: -21.0982
RSI(14) 1m:: 0.0
VWAP:: 2.32
RVol:: 0.0265

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.36 -0.04 (-1.67%)	Oct 15 11:44
1m	Price increase 1m	2.45 +0.03 (+1.42%)	Oct 15 11:16
1m	Price decrease 1m	2.38 -0.03 (-1.31%)	Oct 15 10:33
1m	Price decrease 1m	2.38 -0.04 (-1.45%)	Oct 15 10:14